Cytogenetic and molecular characterization of plutonium-induced rat osteosarcomas. 2010

Sandrine Roch-Lefevre, and Kazuhiro Daino, and Sandrine Altmeyer-Morel, and Marie-Noëlle Guilly, and Sylvie Chevillard
LCE/iRCM/DSV/CEA, route du Panorama, BP 6, 92265 Fontenay-aux-Roses cedex, France.

The association between ionizing radiation and the subsequent development of osteosarcoma has been well described, but little is known about the cytogenetic and molecular events, which could be involved in the formation of radiation-induced osteosarcomas. Here, we performed comparative genomic hybridization (CGH) to detect chromosomal copy number changes in a series of 16 rat osteosarcomas induced by injection of plutonium-238. Recurrent gains/amplifications were observed at chromosomal regions 3p12-q12, 3q41-qter, 4q41-qter, 6q12-q16, 7q22-q34, 8q11-q23, 9q11-q22, 10q32.1-qter, and 12q, whereas recurrent losses were observed at 1p, 1q, 3q23-q35, 5q21-q33, 8q24-q31, 10q22-q25, 15p, 15q, and 18q. The gained region at 7q22-q34 was homologous to human chromosome bands 12q13-q15/8q24/22q11-q13, including the loci of Mdm2, Cdk4, c-Myc and Pdgf-b genes. The lost regions at 5q21-q33, 10q22-q25 and 15q contained tumor suppressor genes such as p16INK4a/p19ARF, Tp53 and Rb1. To identify potential target gene(s) for the chromosomal aberrations, we compared the expression levels of several candidate genes, located within the regions of frequent chromosomal aberrations, between the tumors and normal osteoblasts by using quantitative RT-PCR analysis. The Cdk4, c-Myc, Pdgf-b and p57KIP2 genes were thought to be possible target genes for the frequent chromosomal gain at 7q22-34 and loss at 1q in the tumors, respectively. In addition, mutations of the Tp53 gene were found in 27% (4 of 15) osteosarcomas. Our data may contribute to further understanding of the molecular mechanisms underlying osteosarcomas induced by ionizing radiation in human.

UI MeSH Term Description Entries
D008297 Male Males
D009381 Neoplasms, Radiation-Induced Tumors, cancer or other neoplasms produced by exposure to ionizing or non-ionizing radiation. Radiation-Induced Cancer,Cancer, Radiation-Induced,Radiation-Induced Neoplasms,Cancer, Radiation Induced,Cancers, Radiation-Induced,Neoplasm, Radiation-Induced,Neoplasms, Radiation Induced,Radiation Induced Cancer,Radiation Induced Neoplasms,Radiation-Induced Cancers,Radiation-Induced Neoplasm
D011005 Plutonium A naturally radioactive element of the actinide metals series. It has the atomic symbol Pu, and atomic number 94. Plutonium is used as a nuclear fuel, to produce radioisotopes for research, in radionuclide batteries for pacemakers, and as the agent of fission in nuclear weapons.
D011839 Radiation, Ionizing ELECTROMAGNETIC RADIATION or particle radiation (high energy ELEMENTARY PARTICLES) capable of directly or indirectly producing IONS in its passage through matter. The wavelengths of ionizing electromagnetic radiation are equal to or smaller than those of short (far) ultraviolet radiation and include gamma and X-rays. Ionizing Radiation,Ionizing Radiations,Radiations, Ionizing
D002869 Chromosome Aberrations Abnormal number or structure of chromosomes. Chromosome aberrations may result in CHROMOSOME DISORDERS. Autosome Abnormalities,Cytogenetic Aberrations,Abnormalities, Autosome,Abnormalities, Chromosomal,Abnormalities, Chromosome,Chromosomal Aberrations,Chromosome Abnormalities,Cytogenetic Abnormalities,Aberration, Chromosomal,Aberration, Chromosome,Aberration, Cytogenetic,Aberrations, Chromosomal,Aberrations, Chromosome,Aberrations, Cytogenetic,Abnormalities, Cytogenetic,Abnormality, Autosome,Abnormality, Chromosomal,Abnormality, Chromosome,Abnormality, Cytogenetic,Autosome Abnormality,Chromosomal Aberration,Chromosomal Abnormalities,Chromosomal Abnormality,Chromosome Aberration,Chromosome Abnormality,Cytogenetic Aberration,Cytogenetic Abnormality
D003582 Cytogenetics A subdiscipline of genetics which deals with the cytological and molecular analysis of the CHROMOSOMES, and location of the GENES on chromosomes, and the movements of chromosomes during the CELL CYCLE. Cytogenetic
D004252 DNA Mutational Analysis Biochemical identification of mutational changes in a nucleotide sequence. Mutational Analysis, DNA,Analysis, DNA Mutational,Analyses, DNA Mutational,DNA Mutational Analyses,Mutational Analyses, DNA
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012516 Osteosarcoma A sarcoma originating in bone-forming cells, affecting the ends of long bones. It is the most common and most malignant of sarcomas of the bones, and occurs chiefly among 10- to 25-year-old youths. (From Stedman, 25th ed) Sarcoma, Osteogenic,Osteogenic Sarcoma,Osteosarcoma Tumor,Osteogenic Sarcomas,Osteosarcoma Tumors,Osteosarcomas,Sarcomas, Osteogenic,Tumor, Osteosarcoma,Tumors, Osteosarcoma

Related Publications

Sandrine Roch-Lefevre, and Kazuhiro Daino, and Sandrine Altmeyer-Morel, and Marie-Noëlle Guilly, and Sylvie Chevillard
October 1981, Radiation research,
Sandrine Roch-Lefevre, and Kazuhiro Daino, and Sandrine Altmeyer-Morel, and Marie-Noëlle Guilly, and Sylvie Chevillard
November 2013, Der Pathologe,
Sandrine Roch-Lefevre, and Kazuhiro Daino, and Sandrine Altmeyer-Morel, and Marie-Noëlle Guilly, and Sylvie Chevillard
May 1984, Journal of the National Cancer Institute,
Sandrine Roch-Lefevre, and Kazuhiro Daino, and Sandrine Altmeyer-Morel, and Marie-Noëlle Guilly, and Sylvie Chevillard
January 1980, Neoplasma,
Sandrine Roch-Lefevre, and Kazuhiro Daino, and Sandrine Altmeyer-Morel, and Marie-Noëlle Guilly, and Sylvie Chevillard
August 1993, International journal of cancer,
Sandrine Roch-Lefevre, and Kazuhiro Daino, and Sandrine Altmeyer-Morel, and Marie-Noëlle Guilly, and Sylvie Chevillard
January 1998, Verhandlungen der Deutschen Gesellschaft fur Pathologie,
Sandrine Roch-Lefevre, and Kazuhiro Daino, and Sandrine Altmeyer-Morel, and Marie-Noëlle Guilly, and Sylvie Chevillard
January 1984, Voprosy onkologii,
Sandrine Roch-Lefevre, and Kazuhiro Daino, and Sandrine Altmeyer-Morel, and Marie-Noëlle Guilly, and Sylvie Chevillard
May 1993, American journal of medical genetics,
Sandrine Roch-Lefevre, and Kazuhiro Daino, and Sandrine Altmeyer-Morel, and Marie-Noëlle Guilly, and Sylvie Chevillard
November 2022, Scottish medical journal,
Sandrine Roch-Lefevre, and Kazuhiro Daino, and Sandrine Altmeyer-Morel, and Marie-Noëlle Guilly, and Sylvie Chevillard
March 2003, Genes, chromosomes & cancer,
Copied contents to your clipboard!